Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M HORWITZ

Showing results (511-520 of 831) with videos related to

Pageof 84
Sort By:
Expert Review of Hematology|December 22, 2016
Systemic therapy for cutaneous T-cell lymphoma: who, when, what, and why?Pooja Virmani, Susan H Hwang, Justin G Hastings, et al.
Blood|May 13, 2009
Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablationMassimo Dominici, Valeria Rasini, Rita Bussolari, et al.
Practical Radiation Oncology|November 27, 2014
Evaluating toxicity from definitive radiation therapy for prostate cancer in men with inflammatory bowel disease: Patient selection and dosimetric parameters with modern treatment techniquesColin T Murphy, Steve Heller, Karen Ruth, et al.
The Prostate|December 18, 2023
A pooled patient-reported outcomes analysis of moderately hypofractionated proton beam therapy and photon-based intensity modulated radiation therapy for low- or intermediate-risk prostate cancerAlexander Lukez, Elizabeth Handorf, Nancy P Mendenhall, et al.
Head & Neck|May 1, 1997
The impact of temporary iodine-125 interstitial implant boost in the primary management of squamous cell carcinoma of the oropharynxE M Horwitz, A J Frazier, F A Vicini, et al.
Cancer Gene Therapy|November 23, 2018
Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitorsGiulia Golinelli, Giulia Grisendi, Malvina Prapa, et al.
Cancer Medicine|October 1, 2019
Incidence of benign and malignant peri-implant fluid collections and masses on magnetic resonance imaging in women with silicone implantsElizabeth J Sutton, Brittany Z Dashevsky, Elizabeth J Watson, et al.
International Journal of Radiation Oncology, Biology, Physics|October 23, 1997
Ductal carcinoma in situ detected in the mammographic era: an analysis of clinical, pathologic, and treatment-related factors affecting outcome with breast-conserving therapyF A Vicini, M D Lacerna, N S Goldstein, et al.
American Journal of Clinical Oncology|February 12, 2021
Patient-reported Quality of Life After SBRT, LDR, and HDR Brachytherapy for Prostate Cancer: A Comparison of OutcomesJonathan J Paly, Brian L Egleston, Jessica K Wong, et al.
British Journal of Haematology|August 24, 2005
Primary mediastinal large B-cell lymphoma: optimal therapy and prognostic factor analysis in 141 consecutive patients treated at Memorial Sloan Kettering from 1980 to 1999Paul A Hamlin, Carol S Portlock, David J Straus, et al.
Pageof 84

Showing results (511-520 of 831) with videos related to

Sort By:
Pageof 84
Expert Review of Hematology|December 22, 2016
Systemic therapy for cutaneous T-cell lymphoma: who, when, what, and why?Pooja Virmani, Susan H Hwang, Justin G Hastings, et al.
Blood|May 13, 2009
Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablationMassimo Dominici, Valeria Rasini, Rita Bussolari, et al.
Practical Radiation Oncology|November 27, 2014
Evaluating toxicity from definitive radiation therapy for prostate cancer in men with inflammatory bowel disease: Patient selection and dosimetric parameters with modern treatment techniquesColin T Murphy, Steve Heller, Karen Ruth, et al.
The Prostate|December 18, 2023
A pooled patient-reported outcomes analysis of moderately hypofractionated proton beam therapy and photon-based intensity modulated radiation therapy for low- or intermediate-risk prostate cancerAlexander Lukez, Elizabeth Handorf, Nancy P Mendenhall, et al.
Head & Neck|May 1, 1997
The impact of temporary iodine-125 interstitial implant boost in the primary management of squamous cell carcinoma of the oropharynxE M Horwitz, A J Frazier, F A Vicini, et al.
Cancer Gene Therapy|November 23, 2018
Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitorsGiulia Golinelli, Giulia Grisendi, Malvina Prapa, et al.
Cancer Medicine|October 1, 2019
Incidence of benign and malignant peri-implant fluid collections and masses on magnetic resonance imaging in women with silicone implantsElizabeth J Sutton, Brittany Z Dashevsky, Elizabeth J Watson, et al.
International Journal of Radiation Oncology, Biology, Physics|October 23, 1997
Ductal carcinoma in situ detected in the mammographic era: an analysis of clinical, pathologic, and treatment-related factors affecting outcome with breast-conserving therapyF A Vicini, M D Lacerna, N S Goldstein, et al.
American Journal of Clinical Oncology|February 12, 2021
Patient-reported Quality of Life After SBRT, LDR, and HDR Brachytherapy for Prostate Cancer: A Comparison of OutcomesJonathan J Paly, Brian L Egleston, Jessica K Wong, et al.
British Journal of Haematology|August 24, 2005
Primary mediastinal large B-cell lymphoma: optimal therapy and prognostic factor analysis in 141 consecutive patients treated at Memorial Sloan Kettering from 1980 to 1999Paul A Hamlin, Carol S Portlock, David J Straus, et al.
Pageof 84